Get the content you want anytime you want.
REGISTER NOW | SIGN IN

Healthcare professionals and thought leaders share their knowledge and insights on an array of infectious disease topics

Latest Videos

How Does Ridinilazole Affect the Gut Microbiome?
Dr. Richard Vickers, explains how ridinilazole affected the gut microbiome in participants of a phase 2 study.
 
Treatment Approach for Patients with Potential Lyme Anxiety
Leonard Sigal, MD, explains his approach for treating patients who may have “Lyme anxiety.”
<i>Pseudomonas aeruginosa</i> in the Intensive Care Unit
Marin H. Kollef, MD, discusses Pseudomonas aeruginosa infections within the intensive care unit.
How Much Does It Cost to Develop New Drugs?
Glenn Tillotson, PhD, FIDSA, discusses the costs of drug development.
Factors That Impact <i>C. difficile</i> Infection Recurrence
Following a discussion on how to monitor patients with Clostridium difficile for a response to treatment, Lawrence J. Brandt, MD; Erik Dubberke, MD; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, remark on the risk of recurrence and management of patients’ post therapy and how to proceed if recurrence occurs.
Contaminated Hospital Mattresses Act as Vector for Drug-Resistant Infections
Edmond Hooker, MD, DrPH, discusses how contaminated hospital mattresses act as a vector for spreading drug-resistant infections.
Ridinilazole Shows Superior Efficacy for Treatment of <i>C. diff</i> in Phase 2 Study
Dr. Richard Vickers, discusses how ridinilazole showed superior efficacy for the treatment of C. diff when compared with vancomycin in a phase 2 study.
Preparing to Ensure Effective Stock & Delivery of Future <i>C. diff</i> Vaccine
Richard Haupt, MD, MPH, discusses what is needed to ensure that a future C. diff vaccine is adequately stocked and delivered to wherever individuals show up for vaccination.
FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.